Protocol No.: V59P23; "A Phase 3b, Open Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine when Administered with Routine Infant Vaccinations to Healthy Infants"

Project: Other project

StatusFinished
Effective start/end date4/27/124/26/14

Funding

  • Novartis Vaccines & Diagnostics Inc: $2,928.00